<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Management of opsoclonus-myoclonus-ataxia syndrome in children</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Management of opsoclonus-myoclonus-ataxia syndrome in children</h1>
<div class="graphic"><div class="figure"><div class="ttl">Management of opsoclonus-myoclonus-ataxia syndrome in children</div><div class="cntnt"><img src="data:png;base64,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"/></div><div class="graphic_footnotes"><p>OMAS: opsoclonus-myoclonus-ataxia syndrome; IVIG: intravenous immune globulin; MRI: magnetic resonance imaging; IV: intravenous; ACTH: corticotropin.</p>
* OMAS is associated with neuroblastoma in approximately 50% of cases; symptoms of OMAS may precede discovery of the tumor. Screening protocol for neuroblastoma consists of:
<ul>
<li>Chest, abdominal, and pelvic MRI</li>
<li>Urinary vanillylmandelic acid and homovanillic acid</li>
<li><sup>123</sup>I-metaiodobenzylguanidine (MIBG, iobenguane I-123) scan if MRI results are unrevealing</li>
</ul>
<p class="extra_spacing">Refer to UpToDate topic on diagnosis and staging evaluation of neuroblastoma for further details.</p>
<p>¶ A typical pulsed regimen consists of IVIG plus IV methylprednisolone given over the first 3 to 5 days of each month. Some centers prefer plasma exchange instead of IVIG and ACTH instead of glucocorticoids. Refer to UpToDate topic on OMAS for further details.</p>
<p>Δ The goal of initial immune suppression is to achieve maximal clinical response and sustained remission. Function should be assessed serially in multiple domains, including stance and gait, arm/hand function, opsoclonus, mood/behavior, and speech. Clinical remission is defined as normalization of walking and arm/hand function and resolution of opsoclonus; any residual abnormalities in mood, behavior, and speech should be mild.</p>
◊ Cyclophosphamide is an alternative to rituximab for early add-on therapy. If cyclophosphamide is used initially, rituximab is used subsequently in patients with an insufficient response.</div><div id="graphicVersion">Graphic 140814 Version 1.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
